FLGT FY 2024 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

FY 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$283M-2.0% YoY

Gross Profit

$107M37.8% margin

Operating Income

-$74M-26.1% margin

Net Income

-$43M-15.1% margin

EPS (Diluted)

$-1.41

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

-$19M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$91M

Stockholders' Equity

$1.1B

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$283M	$289M	-2.0%
Gross Profit	$107M	$104M	+2.6%
Operating Income	-$74M	-$196M	+62.2%
Net Income	-$43M	-$168M	+74.6%